Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
Nature Immunology has commissioned a Focus series of Reviews and Perspectives that discuss the innate and adaptive aspects of the immune response to SARS-CoV2, the possible mechanisms behind the large clinical variability in the response to infection, and considerations for vaccine and therapy strategies.
Image: Kateryna Kon / Science Photo Library / Getty
July 2020 marks the 20th anniversary of Nature Immunology's launch. To celebrate, we have commissioned a series of Comments from some of our authors from the last 20 years describing their landmark studies and how they drove immunology research forward.
To support urgent research to combat the ongoing outbreak of COVID-19, caused by the novel coronavirus SARS-CoV-2, the editorial teams at Nature Research have curated a collection of relevant articles.
This collection includes recent articles from across the Nature group of journals and showcases both the latest advances in the methodologies used to study genome organization, and our recent understanding of how genome organization and nuclear architecture regulate gene expression, cell fate and cell function in physiology and disease.
Human immunodeficiency virus (HIV) – the etiologic agent of AIDS – is one of the most intensively studied disease organism in history. Since its first identification in the early 1980s, HIV has transformed into a pandemic, globally infecting more 36 million people and annually contributing to the deaths of hundreds of thousands of patients – particularly in low income countries.